2023-09-07 10:13:39 ET
More on CRISPR Therapeutics
- Seeking Alpha’s Quant Rating on CRISPR Therapeutics
- Historical earnings data for CRISPR Therapeutics
- Financial information for CRISPR Therapeutics
- CRISPR Therapeutics AG ( CRSP ) Presents at Citi's 18th Annual BioPharma Conference Transcript
- Crispr Therapeutics: ICER Puzzles The Prospects
- Vertex And CRISPR Therapeutics - Partners On Exa-cel - But Unequally Valued
- Crispr Therapeutics: Biotech To Watch With Regulatory Approvals Of Exa-Cel On Deck
- Bluebird bio favored at Baird as sickle cell disease space gets busy
- Vertex/CRISPR, bluebird sickle cell therapies could be cost-effective - ICER
- CRISPR Therapeutics upgraded to buy at Citi on near-term approvals
- Why did CRISPR Therapeutics stock soar today? Q2 results
For further details see:
CRISPR Therapeutics announces departure of co-founder Rodger Novak, shares tumble